These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 32027942)

  • 1. Molecular basis for hycanthone drug action in schistosome parasites.
    Guzman M; Rugel A; Tarpley RS; Cao X; McHardy SF; LoVerde PT; Taylor AB
    Mol Biochem Parasitol; 2020 Mar; 236():111257. PubMed ID: 32027942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?
    Rugel AR; Guzman MA; Taylor AB; Chevalier FD; Tarpley RS; McHardy SF; Cao X; Holloway SP; Anderson TJC; Hart PJ; LoVerde PT
    Int J Parasitol Drugs Drug Resist; 2020 Aug; 13():8-15. PubMed ID: 32315953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An iterative process produces oxamniquine derivatives that kill the major species of schistosomes infecting humans.
    Guzman MA; Rugel AR; Tarpley RS; Alwan SN; Chevalier FD; Kovalskyy DP; Cao X; Holloway SP; Anderson TJC; Taylor AB; McHardy SF; LoVerde PT
    PLoS Negl Trop Dis; 2020 Aug; 14(8):e0008517. PubMed ID: 32810153
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy.
    Buchter V; Hess J; Gasser G; Keiser J
    Parasit Vectors; 2018 Nov; 11(1):580. PubMed ID: 30400935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of praziquantel in patients with schistosomiasis mansoni previously treated with oxamniquine and/or hycanthone: resistance of Schistosoma mansoni to schistosomicidal agents.
    de Souza Dias LC; de Jesus Pedro R; Deberaldini ER
    Trans R Soc Trop Med Hyg; 1982; 76(5):652-9. PubMed ID: 7179419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxamniquine derivatives overcome Praziquantel treatment limitations for Schistosomiasis.
    Alwan SN; Taylor AB; Rhodes J; Tidwell M; McHardy SF; LoVerde PT
    PLoS Pathog; 2023 Jul; 19(7):e1011018. PubMed ID: 37428793
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against Schistosoma mansoni and Schistosoma haematobium.
    Hess J; Panic G; Patra M; Mastrobuoni L; Spingler B; Roy S; Keiser J; Gasser G
    ACS Infect Dis; 2017 Sep; 3(9):645-652. PubMed ID: 28686009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzymatic basis for the lack of oxamniquine activity in Schistosoma haematobium infections.
    Pica-Mattoccia L; Novi A; Cioli D
    Parasitol Res; 1997; 83(7):687-9. PubMed ID: 9272559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medicinal chemistry of antischistosomal drugs: Praziquantel and oxamniquine.
    da Silva VBR; Campos BRKL; de Oliveira JF; Decout JL; do Carmo Alves de Lima M
    Bioorg Med Chem; 2017 Jul; 25(13):3259-3277. PubMed ID: 28495384
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schistosomiasis: Drugs used and treatment strategies.
    Siqueira LDP; Fontes DAF; Aguilera CSB; Timóteo TRR; Ângelos MA; Silva LCPBB; de Melo CG; Rolim LA; da Silva RMF; Neto PJR
    Acta Trop; 2017 Dec; 176():179-187. PubMed ID: 28803725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium.
    Kovač J; Vargas M; Keiser J
    Parasit Vectors; 2017 Aug; 10(1):365. PubMed ID: 28764732
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxamniquine resistance alleles are widespread in Old World Schistosoma mansoni and predate drug deployment.
    Chevalier FD; Le Clec'h W; McDew-White M; Menon V; Guzman MA; Holloway SP; Cao X; Taylor AB; Kinung'hi S; Gouvras AN; Webster BL; Webster JP; Emery AM; Rollinson D; Garba Djirmay A; Al Mashikhi KM; Al Yafae S; Idris MA; Moné H; Mouahid G; Hart PJ; LoVerde PT; Anderson TJC
    PLoS Pathog; 2019 Oct; 15(10):e1007881. PubMed ID: 31652296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatal hepatic necrosis in association with hycanthone.
    Hatchuel W
    S Afr Med J; 1978 Nov; 54(20):808. PubMed ID: 741319
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy of oxamniquine and praziquantel in school children from two Schistosoma mansoni endemic areas.
    Thiong'o FW; Mbugua GG; Ouma JH; Sturrock RK
    East Afr Med J; 2002 Jan; 79(1):29-33. PubMed ID: 12380867
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Drug therapy of mansoni schistosomiasis].
    Zeitune JM; Ramos SR; Sugmyama LC; Côrte AA
    Arq Gastroenterol; 1980; 17(2):88-95. PubMed ID: 7213141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term hepatocellular effects of hycanthone and of two other anti-Schistosomal drugs in mice infected with Schistosoma mansoni.
    Haese WH; Bueding E
    J Pharmacol Exp Ther; 1976 Jun; 197(3):703-13. PubMed ID: 180276
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structural and enzymatic insights into species-specific resistance to schistosome parasite drug therapy.
    Taylor AB; Roberts KM; Cao X; Clark NE; Holloway SP; Donati E; Polcaro CM; Pica-Mattoccia L; Tarpley RS; McHardy SF; Cioli D; LoVerde PT; Fitzpatrick PF; Hart PJ
    J Biol Chem; 2017 Jul; 292(27):11154-11164. PubMed ID: 28536265
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Current results in the clinical therapy of schistosomiasis mansoni.
    Katz N
    Rev Inst Med Trop Sao Paulo; 1980; 22(1 Suppl 4):8-17, 123-33. PubMed ID: 7006041
    [No Abstract]   [Full Text] [Related]  

  • 19. Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.
    Fallon PG; Doenhoff MJ
    Am J Trop Med Hyg; 1994 Jul; 51(1):83-8. PubMed ID: 8059919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-schistosomal drugs: observations on the mechanism of drug resistance to hycanthone, and on the involvement of host antibodies in the mode of action of praziquantel.
    Brindley PJ; Sher A
    Mem Inst Oswaldo Cruz; 1987; 82 Suppl 4():157-61. PubMed ID: 3151089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.